A novel sensitive binding assay for quantitation ofa low-molecular-weight phosphomannosyl receptor (41-46 K) was devised. The receptor was immobilized by immunochemical means in the wells of polystyrene multiwell plates. The lysosomal enzyme ligand, testicular o-galactosidase. 'was added and receptor-bound B-galactosidase was measured by conventional colorimettic analysis using p-nitrophenyl &galactoside as substrate. Inhibitors of the binding of 8-galactosidase to the receptor were removed prior to addition of fi-galactosidase and did not interfere with the assay. Low-molecular-weight phosphomannosyl receptor was readily quantitated in the range of 4 to 100 ng of receptor protein.
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Binding of 8- Uptake of extracellular lysosomal enzymes and intracellular transport of newly synthesized enzymes by mammalian cells is mediated by phosphomannosyl receptors ( 1). Two species of membrane-associated receptors which recognize mannose 6-phosphate residues have been reported. High-molecular-weight phosphomannosyl receptor (PMR-lT2 IV, approximately 215,000 by SDS-PAGE) was originally isolated from bovine liver (2) from several mammalian tissues ( 1). Lower molecular weight phosphomannosyl receptors (PMR-2) which exhibit molecular weights in the range of 41-46.000 on SDS-PAGE, have been isolated from bovine testes (3) bovine liver, and a transformed macrophage cell line (4) . PMR-2 is immunologically distinct from PMR-1 and requires addition of divalent cations to bind ligand (3.4) . It has been suggested that PMR-1 and PMR-2 serve as alternate routes for the targeting of lysosomal enzymes (4) .
Studies of the binding characteristics of the lower molecular weight PMR-2 have been hampered by the lack of a suitable assay for its biological activity. The biological properties of PMR-2 have been largely inferred from the capacity of the receptor to bind affinity matrices that contain immobilized proteins and oligosaccharides bearing mannose 6-phosphate residues. These chromato- We now report a novel binding assay for PMR-2 based on the immunochemical immobilization of receptor in the wells of polystyrene multiwell plates. The assay procedure takes advantage of the propensity of immobilized receptor to bind lysosomal /3-galactosidase.
Using this procedure, the characteristics of the binding of lysosomal enzyme to the receptor can be determined. The methodology may be useful for the determination of other receptors that readily dissociate ligand since only a very short time is required to wash the receptor-ligand complex.
MATERIALS AND METHODS
Phosphomannosyl receptors, PMR-1 and PMR-2, were extracted and purified by affinity chromatography on phosphopentamannose-substituted aminoethyl agarose as previously described (2, 3) . Traces of PMR-I were removed from PMR-2 preparations by an additional cycle of affinity chromatography. Affinity-purified bovine testicular /3-galactosidase was prepared by the procedure of Distler and Jourdian (5) . A "high-binding" fraction of P-galactosidase (enriched in enzyme species containing elevated levels of covalently-bound mannose 6-phosphate) was obtained by chromatography on DEAESephacel (6) .
Rabbit antisera to PMR-1 (2) and PMR-2 (3) were prepared as described. Constituents of anti-PMR-2 that reacted with PMR-I were removed by adsorption on a column containing affinity-immobilized PMR-1. PMR-1 (0.5 mg) contained in 1 ml of binding solution (0.5 M NaCl. 0.1% Triton X-100, 0.02% NaN,, and 0.05 M sodium Mes buffer, pH 6.0) was applied to a 1 x Z-cm column of phosphopentamannosesubstituted aminoethyl agarose. The column was washed with 50 ml of the binding solution described above without Triton X-100. Anti-PMR-2 antiserum (10 ml) was applied to the column at 4°C and the column was washed with 10 ml of binding solution lacking Triton X-100. The twofold diluted antiserum did not react with PMR-1 as determined by RIA (7) and a binding assay (3) but retained full activity against PMR-2 in the multiwell assay procedure described below.
Analyses were performed in multiwell Nunc-Immuno Plates I, Intermed Nunc, Denmark. Organic buffers, Hepes and Mes, and affinity-isolated antibody to rabbit IgG (whole molecule, developed in goat) were obtained from Sigma Chemical Co.
Protein content was measured by the procedure of Peterson (8).
Step 1: Preparation qf' untihoc/~~ c.out~~I \~ells. Wells were coated with a solid-phase second antibody affinity-purified anti-rabbit IgG, to spare the primary antiserum (9) . Stock solutions of the second antibody were stored at -20°C in physiological saline at a concentration of 1 mg/ml. One day before assay, stock solutions of the second antibody were diluted to 2.5 pug protein/ml with PBS, pH 8.5, and each well was filled with the diluted solution. The plate was covered and left at room temperature overnight. Excess antibody was removed by aspiration and the wells were washed twice with solution A ( 1% BSA. 0.05% Tween 20, 0.02% NaN3, 0.15 M NaCl, and 0.05 M sodium Hepes, pH 7.2j. The primary antiserum, rabbit anti-PMR-2, was diluted 1:400 from the original serum with solution A, and 200 ~1 was added to each well. The plate was covered and incubated at room temperature on a platform rocker (Adams, Nutator) for 2 h. The wells were aspirated and rinsed two times with solution A, and receptor preparations were added as described below. Diluted primary antiserum could be stored at 4°C for at least 1 week. Diluted antiserum could be reused at least five times without significant loss of receptor-binding capacity.
Stq I: Iinmohilixtion of' rrwptor. Solutions of purified PMR-2, or extracts of tissues to be analyzed, were diluted with solution A to a concentration of 20-200 ng receptor protein/ml and 200~~1 aliquots of the appropriate dilutions were added to the wells. Reagent blanks lacking receptor were also prepared, When crude tissue extracts were analyzed, controls were included to correct for nonspecific binding of /3-galactosidase. In these controls equivalent amounts of crude extract were added to the wells and mannose 6-phosphate was added during subsequent application of @galactosidase.
The receptor solutions were allowed to incubate on the rocker platform for 2 h and the wells were again rinsed two times with solution A prior to addition of ligand.
Step 3: Addition ofligand. Stock solutions of high-binding bovine testicular P-galactosidase (6-8 units/ml) were diluted to 400 munits/ml with solution B (5% BSA. 0.05% Tween 20. 0.02% NaN,. 0.15 M NaCl. 0.02 M MnCl?, and 0.05 M sodium Mes buffer, pH 5.7) and 100~~1 aliquots were placed in each well. Twenty-five microliters of 25 mM mannose 6-phosphate in solution B was added to the control wells described above and 25 ~1 of solution B was added to the remaining wrlls. Inorganic phosphate was excluded from the fl-galactosidase since formation of insoluble manganese phosphate resulted in nonspecific retention of &galac-tosidase in the wells. Phosphate was removed from @galactosidase preparations, if necessary, by dialysis against 100 vol of 0.05 M sodium Mes., pH 5.7, containing 0.02% NaN3. Following incubation of the plate on the rocker platform at room temperature for 2 h, excess &-galactosidase was removed by alternately (four times) flicking the solution from the wells and flooding the plate with a solution consisting of 0.02 M MnQ, 0.15 M NaCl, 0.02% NaN,, and 0.05 M sodium acetate, pH 5.7. The final washing procedure was completed within 2 min to minimize dissociation of ligand from the immobilized receptor.
Step 4: .Ls.sa!3 qf P-~~ulac'to.sida.scJ. A substrate mixture (200 ~1) consisting of 0.19% BSA, 0.15 M NaCl, 0.02% NaN,, 0.0 1 M pnitrophenyl-P-galactopyranoside. and 0.05 M sodium acetate (pH 4.3) was added to each well. The plates were covered and placed at 37°C for 15-20 h. The reaction was stopped by addition of 100 ~1 of 0.5 M glycineNaOH, pH 10. The contents of the wells were mixed and the absorbance was determined at 400 nm in a multiwell plate reader or, alternatively, aliquots were removed from each well and the absorbance was determined in a spectrophotometer. One unit of /S-galactosidase was defined as that amount which produced I pmol p-nitrophenol/min.
RESULTS

AND DISCUSSION
Immobilization of PMR-2 in the wells of multiwell plates was accomplished by combination of direct binding of the receptor to the surface of the polystyrene wells and by use of an immunochemical linking system that increased the amount of bound receptor approximately IO-fold. The immunochemical linking system was composed of a primary antiserum that binds PMR-2 and an affinitypurified anti-rabbit IgG antibody (second antibody) that maximized immobilization of the immunoglobulins contained in the primary antiserum.
Antisera to PMR-2 exhibited cross-reactivity with PMR-1 (3). While the cross-reactivity did not affect the immobilization of purified PMR-2, it prevented specific immo-DISTLER.
PATEL. AND JOURDIAN bilization of PMR-2 from solutions containing both PMR-1 and PMR-2. Antibody against PMR-1 was removed from the primary antiserum by passage through a column of affinity-immobilized PMR-1 as described under Materials and Methods. The adsorbed antiserum was suitable for estimation of PMR-2 in mixtures containing each receptor (see Estimation of PMR-2 in tissue extracts below).
ally, use of the antibodies conferred specificity on the type of phosphomannosyl receptor that was immobilized.
Use ofSecond .4ntihody PMR-2 could be adsorbed to the surface of the polystyrene wells in the absence of the immunochemical linking system. The amount of PMR-2 bound in this fashion approximated 10% of the total receptor added to each well (Fig. 1) . The amount of nonimmunochemically bound PMR-2 increased with the time the receptor was left in the wells and reached a maximum after 3-5 days. At 5 days the response was of the same magnitude as that obtained in 2 h using the immunochemical linking system. Immunochemical linking was, therefore, not essential for immobilization of PMR-2 but its use reduced the time required to immobilize the receptor from several days to 2 h. AdditionPretreatment of the wells with affinity-purified anti-rabbit IgG allowed the use of lower amounts of primary antiserum. For example, when the wells were not treated with the second antibody, 10 times more primary antiserum was required to immobilize an equivalent amount of PMR-2. The optimal amount of second antibody was established by empirical means. When a lofold higher concentration of second antibody was applied to the wells, the amount of PMR-2 that was bound was reduced nearly 50%. Presumably, excessive second antibody leads to inactivation of primary immunoglobulins (9). The conditions for the optimal binding of the enzyme ligand to the receptor could be readily determined by modification of the binding medium. Binding of ligand to lowmolecular-weight forms of phosphomannosyl receptor has been suggested to require a divalent cation (3.4). As shown in Fig. 2 , the presence of MnC12 in the medium increased the amount of P-galactosidase bound to PMR-2 by 50%. The extent of enhancement of ligand binding by MnCl* was affected by the concentration of P-galactosidase as shown in Fig. 3 . At concentrations of P-galactosidase above 500 munits/ml, enhancement of binding by MnCl, was less than 5%. These results suggest that Mn2+ increases the association constant for the receptor-ligand complex. MnC12 (20 mM) was used routinely during ligand binding in the multiwell assay since it permitted the use of a lower optimal concentration of P-galactosidase. MnC12 was not required for the attachment of antibodies or immobilization of PMR-2 in the wells. In The multiwell binding assay was performed as described under Materials and Methods except /%galactosidase was reduced to 150 munits/ml in Slep 3 to enhance the effect of MnClz concentration (see Fig. 3 ).
a similar multiwell binding assay performed with PMR-1 and anti-PMR-1 primary antiserum, MnC'l* did not significantly affect binding of /3-galactosidase to PMR-1 (results not shown).
The optimum pH for binding of P-galactosidase to PMR-2 was determined by alter- ing the pH of the binding medium (Fig. 4) . A pH of 5.7 was selected for estimations of PMR-2: this pH value also proved to be optimal for the assay of PMR-I (results not shown).
Determination of PMR-2 PMR-2 can be estimated by the multiwell binding assay in the range of 4-100 ng receptor protein/well (Fig. 1) . Above this range the response to PMR-2 was reduced, presumably because bound antibody became limiting. Attempts to increase the capacity of the wells to bind PMR-2 by increasing time of incubation and by addition of larger amounts of primary antisera were unrewarding. Maximum immunochemical reaction was achieved in 2 h and even a IO-fold increase in primary antiserum resulted in < 10% increase in the level of PMR-2 bound.
Control wells that contained 5 mM mannose 6-phosphate did not retain measurable levels of @-galactosidase when purified PMR-2 was being measured (Fig. 1) A second problem with assay of PMR-2 in crude extracts results from nonspecific binding of fl-galactosidase in the wells (retention of P-galactosidase in the presence of 5 mM mannose 6-phosphate).
This occurs when serum or crude Triton X-100 extracts of tissues have been applied to the wells (Table 1) . Frequently a visible film may be seen on the surface of the wells and &galactosidase adheres to the residue. The substances responsible for this nonspecific binding of P-galactosidase have not been identified.
For the reasons described above, crude tissue extracts tend to yield multiwell values for PMR-2 that are higher than those obtained by RIA. However, the multiwell procedure has proved accurate and convenient for monitoring PMR-2 fractions following initial purification steps. The procedure is of particular value for large numbers of samples containing low levels of PMR-2 and for assay of PMR-2 when the biological activity must be determined.
In addition, the multiwell assay procedure has been modified in this laboratory to screen polyclonal and mono- clonal antibo'dy fractions. In this case the appropriate species-directed anti-IgG second antibody is employed along with the primary anti-PMR-2 immunoglobulins from ascites fluids. or serum samples.
